Page last updated: 2024-09-03
mosapride and atropine
mosapride has been researched along with atropine in 1 studies
Compound Research Comparison
| Studies (mosapride) | Trials (mosapride) | Recent Studies (post-2010) (mosapride) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
|---|---|---|---|---|---|
| 286 | 90 | 142 | 26,711 | 1,259 | 1,697 |
Protein Interaction Comparison
| Protein | Taxonomy | mosapride (IC50) | atropine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bao, YR; Chang, X; Li, TJ; Meng, XS; Wang, S; Yu, XM | 1 |
Other Studies
1 other study(ies) available for mosapride and atropine
| Article | Year |
|---|---|
Multicomponent, multitarget integrated adjustment - Metabolomics study of Qizhiweitong particles curing gastrointestinal motility disorders in mice induced by atropine.
Topics: Animals; Atropine; Benzamides; Biomarkers; Chromatography, High Pressure Liquid; Chromatography, Liquid; Disease Models, Animal; Domperidone; Drugs, Chinese Herbal; Gastrointestinal Agents; Gastrointestinal Diseases; Gastrointestinal Motility; Least-Squares Analysis; Male; Metabolomics; Mice, Inbred ICR; Molecular Targeted Therapy; Morpholines; Multivariate Analysis; Phytotherapy; Plants, Medicinal; Principal Component Analysis; Signal Transduction; Systems Biology; Tandem Mass Spectrometry | 2016 |